ABG-WTT Global Life Science Capital Partners GP Ltd
Follow13F filer, CIK 1832108, CENTRAL, HONG KONG, Hong Kong
ABG-WTT Global Life Science Capital Partners GP Ltd reported $15,049,171 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-055042
- Period
- 2025-12-31
- Reported value
- $15M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CBLLreduced | -646,281 | -$14.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001193125-26-055042, largest first. % of portfolio is the value over $15,049,171, the sum of the share positions whose value is usable for ratios (method).
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-055042 | base | 2026-02-17 | acceptance time not in the bulk data set |